Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis

BACKGROUND: To identify the most cost-beneficial model as a national policy of screening and diagnosis of fetal Down syndrome (DS) in developing countries. METHODS: Cost-benefit analysis (CBA) was performed based on the effectiveness and probabilities derived from a large prospective study on MSS (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanapirak, Chanane, Buddhawongsa, Piyaluk, Himakalasa, Woraluck, Sarnwong, Auttapan, Tongsong, Theera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880440/
https://www.ncbi.nlm.nih.gov/pubmed/31775720
http://dx.doi.org/10.1186/s12913-019-4699-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880440/
https://www.ncbi.nlm.nih.gov/pubmed/31775720
http://dx.doi.org/10.1186/s12913-019-4699-4

Ejemplares similares